Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-04-10
2009-02-24
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S575000, C548S561000, C562S621000
Reexamination Certificate
active
07495022
ABSTRACT:
Disclosed are agents that inhibit histone deacetylase. More specifically, the present invention relates to novel hydroxamic acid derivatives or pharmaceutically acceptable salts thereof for anticancer agents or other therapeutic agents based on their histone deacetylase inhibitory activity.
REFERENCES:
patent: WO 01/38322 (2001-05-01), None
patent: WO 02/22577 (2002-03-01), None
Bang Young-Jue
Choi Jin Young
Im Guang-Jin
Kim Dae-Kee
Kim Jae-Sun
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Saeed Kamal A
SK Chemicals Co. Ltd.
LandOfFree
α,β-unsaturated hydroxamic acid derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α,β-unsaturated hydroxamic acid derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α,β-unsaturated hydroxamic acid derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4068326